These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2460954

  • 1. [Prolonged medical therapy using mepartricin in prostatic hypertrophy. Results in 81 patients].
    Serretta V, Pavone C, Di Trapani D, Romano C, Costa G, Caramia G.
    Minerva Urol Nefrol; 1988; 40(2 Suppl):55-8. PubMed ID: 2460954
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of benign prostatic hypertrophy using mepartricin at high dosage].
    Giurioli A, Rosi P, Parziani S, Cesaroni M, Ghamari MR.
    Minerva Urol Nefrol; 1988; 40(2 Suppl):38-9. PubMed ID: 2460947
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of the use of mepartricin in the therapy of prostatic hypertrophy. Double-blind study].
    Cortecchia V, Scarano P, D'Amato G, Soli M, Rusconi R, Buli P.
    Minerva Urol Nefrol; 1988; 40(2 Suppl):44-6. PubMed ID: 2460949
    [No Abstract] [Full Text] [Related]

  • 4. [Use of mepartricin in the patient suffering from so-called benign prostatic hypertrophy. Study of 142 cases].
    Fiorilla C.
    Minerva Urol Nefrol; 1988; 40(2 Suppl):35-7. PubMed ID: 2460946
    [No Abstract] [Full Text] [Related]

  • 5. [Randomized double-blind study using mepartricin and a placebo in the therapy of benign prostatic hypertrophy].
    Miano L, Manieri C, Paradiso Galatioto G.
    Minerva Urol Nefrol; 1988; 40(2 Suppl):50-2. PubMed ID: 2460952
    [No Abstract] [Full Text] [Related]

  • 6. [Use of mepartricin in the treatment of benign prostatic hypertrophy. Open study of 39 patients].
    Montanari E, Patelli E, Mandressi A, Magri V, Pisani E.
    Minerva Urol Nefrol; 1988; 40(2 Suppl):25-9. PubMed ID: 2460942
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Evaluation of the objective efficacy of mepartricin in benign prostatic hypertrophy].
    Cirillo Marucco E, Giocoli Nacci G, Pagliarulo A, Balacco G, Ludovico G.
    Minerva Urol Nefrol; 1988; 40(2 Suppl):23-4. PubMed ID: 2460941
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical experience with mepartricin in the treatment of prostatic hypertrophy. Preliminary results].
    Bassi P, Oliva G, Tasca A, Aragona F, Milani C, Zattoni F.
    Minerva Urol Nefrol; 1988; 40(2 Suppl):40-3. PubMed ID: 2460948
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical and echographic evaluation of a group of 40 patients suffering from benign prostatic hypertrophy treated with mepartricin].
    Alei G.
    Minerva Urol Nefrol; 1988; 40(2 Suppl):59-61. PubMed ID: 2460955
    [No Abstract] [Full Text] [Related]

  • 12. [Latest contribution concerning the use of mepartricin in adenoma of the prostate].
    Comar OB, Di Rienzo A.
    Minerva Urol Nefrol; 1988; 40(2 Suppl):30-2. PubMed ID: 2460944
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Role of mepartricin in patients with benign prostatic hypertrophy. Study of 24 patients].
    Fiorilla C, Mosele G.
    Minerva Urol Nefrol; 1987; 39(4):369-72. PubMed ID: 2453930
    [No Abstract] [Full Text] [Related]

  • 15. [Evaluation of the pharmacological effect of mepartricin in urological pathology by prostatic superficial echotomography].
    Gasparini-Casari M, Palmieri B, Noera G, Ferrari P.
    Minerva Urol; 1980; 32(1):5-10. PubMed ID: 6155599
    [No Abstract] [Full Text] [Related]

  • 16. [Mepartricin in the treatment of benign prostatic hyperplasia].
    Cirillo Marucco E, Pagliarulo A, Piccinno A, Di Rienzo U.
    Minerva Urol Nefrol; 1988; 40(2):101-4. PubMed ID: 2459784
    [No Abstract] [Full Text] [Related]

  • 17. [Medical treatment of benign prostatic hypertrophy. Echographic evaluation].
    Traficante A, Martino P, Battaglia M.
    Minerva Urol Nefrol; 1988; 40(2 Suppl):47-9. PubMed ID: 2460950
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Double-blind study on the effects of mepartricin (SPA-S-160) versus placebo in the treatment of obstruction caused by adenoma of the prostate].
    Rizzo M, Tosto A, Dattolo E, Serni S.
    Minerva Urol Nefrol; 1988; 40(2 Suppl):21-2. PubMed ID: 2460940
    [No Abstract] [Full Text] [Related]

  • 20. [Mepartricin in prostatic hypertrophy. Results in 20 cases].
    Durval A, Rovereto B, Tosto A, Paoletti MC, Natali A, Pellegrini GL.
    Minerva Urol Nefrol; 1986; 38(1):81-5. PubMed ID: 2426804
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.